Progesterone inhibits arterial smooth muscle cell proliferation

Nature Medicine

Volumn 3, Issue 9, 1997, Pages 1005-1008

  Lee, Wen Sen ^a,b,d   Harder, Justin A ^a,e   Yoshizumi, Masao ^a,b,f   Lee, Mu En ^a,b,c   Haber, Edgar ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN E; ESTROGEN; GESTAGEN; MESSENGER RNA; MIFEPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; ATHEROSCLEROSIS; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY RISK; DNA SYNTHESIS; FEMALE; HEART PROTECTION; HUMAN; MALE; NONHUMAN; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE RELEASE; RAT; SMOOTH MUSCLE FIBER;

ANIMALS; ARTERIES; ARTERIOSCLEROSIS; CELL DIVISION; CELLS, CULTURED; CYCLINS; DNA; DOWN-REGULATION; FEMALE; HUMANS; MALE; MIFEPRISTONE; MUSCLE, SMOOTH, VASCULAR; PROGESTERONE; RATS; RECEPTORS, PROGESTERONE; RNA, MESSENGER;

ANIMALIA;

EID: 0030770730     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0997-1005     Document Type: Article

References (24)

1. McGill, H.C., Jr., & Stern, M.P. Sex and atherosclerosis. Atheroscler. Rev. 4, 157-242 (1979).
2. Stampfer, M.J, et al. Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses' Health Study. N. Engl. J. Med. 325, 755-762 (1991).
3. Grodstein, F. et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N. Engl. J. Med. 335, 453-461 (1996).
4. Stamler, J., Pick, R. & Katz, L.N. Prevention of coronary atherosclerosis by estrogen-androgen administration in the cholesterol-fed chick. Circ. Res. 1, 94-98 (1953).
5. Weigensberg, B.I. et al. Effects of estradiol on myointimal thickenings from catheter injury and on organizing white mural non-occlusive thrombi. Atherosclerosis 52, 253-265 (1984).
6. Sullivan, T.R., Jr., et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J. Clin. Invest. 96, 2482-2488 (1995).
7. Kushwaha, R.S., Lewis, D.S., Carey, K.D. & McGill, H.C., Jr. Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papro sp.). Arteriosder. Thromb. 11, 23-31 (1991).
8. Williams, J.K. & Adams, M.R. Estrogens, progestins and coronary artery reactivity. Nature Med. 3, 273-274 (1997).
9. Miyagawa, K., Rösch, J., Stanczyk, F. & Hermsmeyer, K. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm. Nature Med. 3, 324-327 (1997).
10. Murray, T.R., Marshall, B.E. & Macarak, E.J. Contraction of vascular smooth muscle in cell culture. J. Cell. Physiol. 143, 26-38 (1990).
11. Morgan, K.G., DeFeo, T.T., Wenc, K. & Weinstein, R. Alterations of excitation-contraction coupling by platelet-derived growth factor in enzymatically isolated and cultured vascular smooth muscle cells. Pfluegers Arch. 405, 77-79 (1985).
12. Shaaban, M.M. & Klopper, A. Plasma oestradiol and progesterone concentration in the normal menstrual cycle. J. Obstet. Cynaecol. Br. Commonw. 80, 776-782 (1973).
13. Challis, J.R.G., Workewych, J. V. & Patrick, J. E. Diurnal changes in the concentration of progesterone in the plasma of women at 34-35 weeks of gestation. J. Endocrinol. 89, 337-341 (1981).
14. Ingegno, M.D. et al. Progesterone receptors in the human heart and great vessels. Lab. Invest. 59, 353-356 (1988).
15. Farhat, M.Y., Vargas, R., Dingaan, B. & Ramwell, P.W. In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: Role of the endothelium. Br. J. Pharmacol. 107, 679-683 (1992).
16. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273, 199-208 (1995).
17. Knauthe, R., Diel, P., Hegele-Hartung, C., Engelhaupt, A. & Fritzemeier, K.-H. Sexual dimorphism of steroid hormone receptor messenger ribonucleic acid expression and hormonal regulation in rat vascular tissue. Endocrinology 137, 3220-3227 (1996).
18. Lees, E. Cyclin dependent kinase regulation. Curr. Opin. Cell Biol. 7, 773-780 (1995).
19. Sherr, C.J. Mammalian G1 cyclins. Cell 73, 1059-1065 (1993).
20. Tsai, J.-C. et al. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc. Natl. Acad. Sci. USA 91, 6369-6373 (1994).
21. Lee, W.-S., Smith, M.S. & Hoffman, G.E. Luteinizing hormone-releasing hormone neurons express Fos protein during the proestrous surge of luteinizing hormone. Proc. Natl. Acad. Sci. USA 87, 5163-5167 (1990).
22. Yoshizumi, M. et al. Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J. Clin. Invest. 95, 2275-2280 (1995).
23. Lee, M.-E., Temizer, D.H., Clifford, J.A. & Quertermous, T. Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells. J. Biol. Chem. 266, 16188-16192 (1991).
24. Lee, W.-S., Kanai, Y., Wells, R.G. & Hediger, M.A. The high affinity Na+/glucose co-transporter: Re-evaluation of function and distribution of expression. J. Biol Chem. 269, 12032-12039 (1994).